Us Bancorp »

Crescent Biopharma shares owned by Us Bancorp

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Us Bancorp

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.3k 403 18.00

More positions owned by Us Bancorp

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Ishares Tr Rus Mid Cap Etf (IWR)
JPMorgan Chase & Co. (JPM)

View all positions for Us Bancorp

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Logos Global Management
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
BlackRock
Tang Capital Management
Vanguard Capital Management
Millennium Management
Geode Capital Management
Jennison Associates

View all funds holding Crescent Biopharma